Compare
Tactile Systems Technology Inc vs PROCEPT BioRobotics Corp vs Accuray Inc vs Mimedx Group, Inc.
| Latest fiscal year | Tactile Systems Technology Inc TCMD | PROCEPT BioRobotics Corp PRCT | Accuray Inc ARAY | Mimedx Group, Inc. MDXG |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | $329.52M | $308.05M | $401.95M | $418.63M |
| Revenue growth (YoY) | +12.5% | +37.2% | -12.3% | +20.0% |
| Gross margin | 75.9% | 63.7% | 27.7% | 82.6% |
| Operating margin | 8.9% | -33.7% | -6.6% | 15.3% |
| Net margin | 5.8% | -31.0% | -12.2% | 11.6% |
| Net income | $19.09M | -$95.57M | -$49.19M | $48.58M |
| EPS (Diluted) | $0.82 | -$1.72 | n/a | $0.32 |
| Operating cash flow | $42.81M | -$48.98M | -$6.98M | $74.00M |
| Free cash flow | $40.43M | -$58.34M | -$12.84M | n/a |
| Cash & equivalents | $83.45M | $286.50M | $40.62M | $166.12M |
| Total assets | $273.94M | $508.08M | $443.68M | $342.65M |
| Total liabilities | $55.04M | $142.21M | $401.98M | $86.11M |
| Shareholders' equity | $218.90M | $365.87M | $41.70M | $256.55M |
| Return on year-end equity | 8.7% | -26.1% | -118.0% | 18.9% |
| Shares outstanding | 22.44M | 56.32M | 119.43M | 148.09M |
Revenue, most recent five fiscal years
| Fiscal year | Tactile Systems Technology Inc | PROCEPT BioRobotics Corp | Accuray Inc | Mimedx Group, Inc. |
|---|---|---|---|---|
| Latest | $329.52M Ended 2025-12-31 | $308.05M Ended 2025-12-31 | $401.95M Ended 2026-06-30 | $418.63M Ended 2025-12-31 |
| 1 year earlier | $292.98M Ended 2024-12-31 | $224.50M Ended 2024-12-31 | $458.50M Ended 2025-06-30 | $348.88M Ended 2024-12-31 |
| 2 years earlier | $274.42M Ended 2023-12-31 | $136.19M Ended 2023-12-31 | $446.55M Ended 2024-06-30 | $321.48M Ended 2023-12-31 |
| 3 years earlier | $246.78M Ended 2022-12-31 | $75.01M Ended 2022-12-31 | $447.61M Ended 2023-06-30 | $267.84M Ended 2022-12-31 |
| 4 years earlier | $208.06M Ended 2021-12-31 | $34.47M Ended 2021-12-31 | $429.91M Ended 2022-06-30 | $242.02M Ended 2021-12-31 |